All News #Library
Quality
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
Akari skyrockets as FDA clears pivotal trial for dual-action in pediatric TMA
14 Mar 2019 //
BIOWORLD
Alexion issued new FDA Form 483 for Rhode Island plant
09 Aug 2016 //
FIERCE MANUFACTURING

Market Place
Sourcing Support